tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NXTC Stock Latest News

NextCure announces preclinical data on NC605
The FlyNextCure announces preclinical data on NC605
4d ago
NXTC
NextCure Reports Improved Financial Performance and Strategic Focus
PremiumCompany Announcements
NextCure Reports Improved Financial Performance and Strategic Focus
11d ago
NXTC
NextCure to Discuss Innovative Cancer Therapies
PremiumCompany Announcements
NextCure to Discuss Innovative Cancer Therapies
15d ago
8K
NXTC
NextCure reports Q3 EPS (41c), consensus (34c)
PremiumThe Fly
NextCure reports Q3 EPS (41c), consensus (34c)
16d ago
NXTC
NextCure reports data from LNCB74, NC410 studies
PremiumThe Fly
NextCure reports data from LNCB74, NC410 studies
18d ago
NXTC
NXTC Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsNXTC Upcoming Earnings Report: What to Expect?
25d ago
NXTC
NextCure announces data from Phase 1b trial evaluating NC410
Premium
The Fly
NextCure announces data from Phase 1b trial evaluating NC410
2M ago
NXTC
NextCure reports Q2 EPS (55c), consensus (38c)
Premium
The Fly
NextCure reports Q2 EPS (55c), consensus (38c)
4M ago
NXTC
NextCure presents Phase 1b data on NC410 and pembrolizumab combo at ASCO
PremiumThe Fly
NextCure presents Phase 1b data on NC410 and pembrolizumab combo at ASCO
6M ago
NXTC
NextCure treatment of osteogenesis imperfecta granted orphan designation
PremiumThe Fly
NextCure treatment of osteogenesis imperfecta granted orphan designation
6M ago
NXTC
NextCure reports Q1 EPS (61c), consensus (46c)
PremiumThe Fly
NextCure reports Q1 EPS (61c), consensus (46c)
7M ago
NXTC
NextCure and LCB present data on B7-H4 antibody drug conjugate at AACR
PremiumThe Fly
NextCure and LCB present data on B7-H4 antibody drug conjugate at AACR
8M ago
NXTC
NextCure appoints Rakesh Dixit to Scientific Advisory Board
PremiumThe FlyNextCure appoints Rakesh Dixit to Scientific Advisory Board
8M ago
NXTC
NextCure Inc to Engage with Investors in Informal Talks
Premium
Company Announcements
NextCure Inc to Engage with Investors in Informal Talks
8M ago
8K
NXTC
NextCure restructures operations, reduces workforce by 37%
Premium
The Fly
NextCure restructures operations, reduces workforce by 37%
8M ago
NXTC
NextCure announces intention to partner assets
PremiumThe Fly
NextCure announces intention to partner assets
8M ago
NXTC
NextCure to prioritize NC410 combo, LNCB74 in 2024
PremiumThe Fly
NextCure to prioritize NC410 combo, LNCB74 in 2024
8M ago
NXTC
NextCure expects resources to fund operations into 2H26
PremiumThe Fly
NextCure expects resources to fund operations into 2H26
8M ago
NXTC
NextCure reports 2023 EPS ($2.25), consensus ($2.28)
PremiumThe Fly
NextCure reports 2023 EPS ($2.25), consensus ($2.28)
8M ago
NXTC
NextCure’s treatment of AML granted FDA orphan designation
PremiumThe FlyNextCure’s treatment of AML granted FDA orphan designation
9M ago
NXTC
NextCure publishes preclinical data on function of FLRT3
Premium
The Fly
NextCure publishes preclinical data on function of FLRT3
9M ago
NXTC
NextCure presents preclinical VSTM-1 data
Premium
The Fly
NextCure presents preclinical VSTM-1 data
10M ago
NXTC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >